First Friday Book Synopsis

JUNE 27, 2013

Bob''s blog entries Biotechnology and Biological Sciences Research Council Brasenose College at the University of Oxford James Duncan Davidson Margaret Thatcher: “Sleep is for wimps” Royal Society Sleep is for energy conservation [comma] to save calories Sleep is for restoration [comma] to replenish and repair metabolic processes Sleep: A Very Short Introduction Steven W. Here is an excerpt from an article posted by Thu-Huong Ha at the TED website.

Biotechnology 75

Biotechnology Film Books Article 75

Career Advancement

SEPTEMBER 27, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. “We think, mistakenly, that success is the result of the amount of time we put in at work, instead of the quality of time we put in.”

Tips 296

Tips Career Biotechnology Objective 296

Career Advancement

SEPTEMBER 27, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. “We think, mistakenly, that success is the result of the amount of time we put in at work, instead of the quality of time we put in.”

Tips 296

Tips Career Biotechnology Objective 296

N2Growth Blog

FEBRUARY 10, 2021

Genentech is a global biotechnology company that created an entire drug discovery industry.

Tacit Knowledge 383

Tacit Knowledge Biotechnology Wilde Sports 383

Career Advancement

OCTOBER 12, 2020

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. “We think, mistakenly, that success is the result of the amount of time we put in at work, instead of the quality of time we put in.”

Tips 296

Tips Career Biotechnology Objective 296

Career Advancement

JULY 1, 2019

For example, a multi-billion-dollar biotechnology company recently contacted me for a training on executive presence to help newly minted high-potential mid-level managers reach the next level of leadership. “Leadership is lifting a person’s vision to high sights, the raising of a person’s performance to a higher standard, the building of a personality beyond its normal limitations.” Peter Drucker.

Training 179

Training Execution Human Capital Biotechnology 179

Career Advancement

MAY 25, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. “We think, mistakenly, that success is the result of the amount of time we put in at work, instead of the quality of time we put in.”

Career 156

Career Tips Biotechnology Objective 156

Tanveer Naseer

OCTOBER 20, 2015

The first leader was someone I worked with as part of the management team at a biotechnology firm, and how he guided our organization during the merger of our North American parent company with a much larger European multinational. If I were to ask you what you thought was the greatest invention in human history, what would be your reply? I imagine for some of you, your answer would be the personal computer and all the technological marvels that now make up our digital world.

Power 278

Power Uncertainty Biotechnology Charisma 278

Tanveer Naseer

JUNE 2, 2015

Dan was the president of a biotechnology company where I served in my first middle management role. Over the past few weeks, I’ve been writing about the various characteristics and perspectives leaders need to have to be successful in bringing out the best in those they lead. Sharing some of these insights has brought to mind a question I was asked recently following one of my presentations on leadership.

Emotional Intelligence 279

Emotional Intelligence Biotechnology Audience Proposal 279

First Friday Book Synopsis

MARCH 8, 2011

He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health. John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders.

Biotechnology 85

Biotechnology Pharmaceuticals Books Consultative 85

Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. When business owners are successful, it’s only natural to start considering how they can make the most of their profits and savings. Many of these people decide to invest in other companies to get a return as they generate wealth, but it’s important to understand which industries represent the most stable investments.

Biotechnology 66

Biotechnology Strategy Health Care Insurance 66

The Idolbuster

AUGUST 28, 2012

While Silicon Valley is best known for their technology companies – Google, Yahoo, Apple, Hewlett Packard, Intel, and Facebook to name a few, the Bay Area is also home to some of the most cutting edge biotechnology and medical device companies. The job at a small biotechnology company was a great match for his skills. Chapter 4: Who To Trust At Work Post 2.

Biotechnology 38

Biotechnology Performance Review Technology Review 38

Great Leadership By Dan

JUNE 8, 2017

Guest post from Amy Blankson: In 2013, the National Center for Biotechnology Information reported that the average attention span of a human has dropped to a mere eight seconds , one second behind that of a goldfish. Why does this matter? Distraction in the digital era has become an epidemic, robbing us of our focus, decreasing our productivity and hindering our overall life satisfaction.

Management 161

Management Biotechnology Leadership Short-term 161

HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. On May 11, Moderna announced that its Chief Financial officer will be leaving the company after spending just one day in office.

CFO 36

CFO Biotechnology Due Diligence Chief Financial Officer 36

HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. On May 11, Moderna announced that its Chief Financial officer will be leaving the company after spending just one day in office.

CFO 36

CFO Biotechnology Due Diligence Chief Financial Officer 36

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop.

Bureaucracy 217

Bureaucracy Compliance Biotechnology Telecommunications 217

Strategy Driven

MAY 12, 2021

Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential. They say a picture’s worth a thousand words. In 3D displays, it’s worth a million.

Strategy 97

Strategy Biotechnology Content Wireless 97

Skip Prichard

JULY 22, 2019

Unfortunately, many of us have developed expertise in only one field (software engineering, information technology [IT], marketing, biotechnology, automobile manufacturing, the food industry, etc. Innovation Capital. A great idea may not be enough to build a great business. Whether you have invented an amazing new technology or product, you could still fail. And one of the most overlooked reasons for entrepreneurial failure is innovation capital.

Innovation 77

Innovation Reputation Human Capital Biotechnology 77

The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. Chapter 9: Paint Your Environment: Part 5. As I argued in the last post , if you want the company to do the right thing, make sure you have a set of numbers to back it up. To fully understand why I think this is critical, lets step back for a moment and look at where a revenue forecast come from.

Biotechnology 41

Biotechnology Groupthink CFO Reference 41

The Idolbuster

JANUARY 25, 2013

Prior to launching her wellness practice, she worked in the management consulting industry and at one of the leading cancer research biotechnology companies. Self Portrait By Jillian Corinne Via Flickr CC. A guest post by Health Coach Catherine Chen, Ph.D. Do you sometimes fall into this trap? If I finish this project, then I can relax. If I get approval from my boss, then I will feel more competent. If I work on what I want, then I’ll feel like I’m making a difference. “If-then”

Biotechnology 41

Biotechnology Succession Banking Project 41

Harvard Business Review

APRIL 8, 2014

For example, if you are a biotechnology fund manager who wants to communicate the importance of investing in biotechnology, you may think that your value is in your recent success in investing for shareholders, but if you are a reasonable person, you will likely also have doubts about this. How will they feel about the fact that you have a history of success in biotechnology investing?

Biotechnology 8

Biotechnology Audience Review Commitment 8

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies.

IPO 14

IPO Biotechnology Venture Capitalist Finance 14

Harvard Business Review

JULY 11, 2018

However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. Patricia de Melo Moreira/bloomberg/Getty Images. It’s widely believed that the most successful entrepreneurs are young. Bill Gates, Steve Jobs, and Mark Zuckerberg were in their early twenties when they launched what would become world-changing companies. Do these famous cases reflect a generalizable pattern? VC and media accounts seem to suggest so.

IPO 16

IPO Biotechnology Entrepreneur Industry 16

Harvard Business Review

JANUARY 5, 2012

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. These technologies improve productivity and facilitate better living standards when they penetrate into societies.

Information Technology 15

Information Technology Biotechnology Information Chemicals 15

Harvard Business Review

MARCH 13, 2012

Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa? One thing that the Chinese do quite well — and that the U.S. could learn from — is to test policy proposals before rolling them out nationally. A new approach is often tried out first in several cities or provinces to make sure it has the intended effect, and to check for unintended consequences.

Biotechnology 14

Biotechnology Tourism Banking Real Estate 14

Harvard Business Review

MAY 2, 2011

Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese. Nokia's recent burning platform travails serve as an object lesson to companies trying to navigate a rapidly-changing global economy. As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa.

Biotechnology 15

Biotechnology Venture Capitalist Telecommunications Comparison 15

Harvard Business Review

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. One of the conundrums of ethical decision making is that many moral decisions that are quite straightforward — even easy — to resolve in a classroom or during training exercises seem far more difficult to successfully resolve when confronted during actual day-to-day decision making.

Biotechnology 13

Biotechnology Hedge Morale McKinsey 13

Harvard Business Review

NOVEMBER 29, 2016

From our unique vantage points at Genentech , a leading biotechnology company with a major data science practice, and The Data Incubator , a data-science education company that places and trains data scientists , we have seen how the pharmaceuticals industry has leveraged big data for some potentially revolutionary advances and the challenges it has faced along the way.

Incubator 10

Incubator Biotechnology Health Care Compliance 10

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Despite the East Coast roots of technology entrepreneurship and venture capital (VC), by the 1990s Silicon Valley had gained a major advantage over the Cambridge-Boston area. In 1995 Silicon Valley’s share of all VC investments in the U.S.

Biotechnology 9

Biotechnology Drucker Software Entrepreneur 9

Harvard Business Review

MARCH 30, 2017

We worked with a startup biotechnology company. Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. Over recent decades the rightful endeavor to achieve a more representative workforce has had an impact. Of course, there is a ways to go, but progress has been made.

Biotechnology 15

Biotechnology Diversity Review Execution 15

Harvard Business Review

APRIL 27, 2012

There are intriguing signs that we might be approaching the point where digital innovation takes a big leap into the physical world: 3D printers are breaking into the mainstream , tech billionaires are backing an asteroid mining venture , and lots of people keep saying that biotechnology is the next great frontier. It's an age of unprecedented, staggering technological change. Business models are being transformed, lives are being upended, vast new horizons of possibility opened up.

Stephenson 15

Stephenson Biotechnology Gordon eBook 15

Harvard Business Review

JUNE 4, 2018

“Together, in response to industry demand, we’re creating a dedicated pipeline of skilled biomanufacturing professionals,” said Bruce Van Dyke, chair of Quincy’s Biotechnology and Good Manufacturing Practice program, in a recent interview with us. Bernhard Lang/Getty Images. Although it’s hard to pinpoint when skills shortages became the norm in the U.S.,

Biotechnology 9

Biotechnology Human Capital Review Industry 9

Harvard Business Review

MARCH 28, 2012

In pharma, Johnson & Johnson's 1999 acquisition of Centocor brought in blockbuster biotechnology innovations led by rheumatoid arthritis drug Remicade. The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. In January, after Illumina's board rebuffed Roche's initial overtures, Roche made a $5.7 billion tender offer directly to shareholders.

Biotechnology 15

Biotechnology CFO Pharmaceuticals Letter 15

Harvard Business Review

MARCH 2, 2012

French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 15

Competitive Advantage Biotechnology Intellectual Capital Pharmaceuticals 15

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. MINCHU/Getty Images. In a work culture with too many meetings, we often look for tactics to get out of meetings. But sometimes you need to get into a meeting, perhaps because the decisions made there will have implications for you or your team, or maybe because you feel you’ve been left out of important discussions.

Restructuring 12

Restructuring Biotechnology Compliance Rogers 12

Harvard Business Review

JUNE 23, 2015

Exciting applications have already been demonstrated across all sectors — from aerospace and medical applications to biotechnology and food production. Contrary to what some say , 3D printing is not going to revolutionize the manufacturing sector, rendering traditional factories obsolete. The simple fact of the matter is the economics of 3D printing now and for the foreseeable future make it an unfeasible way to produce the vast majority of parts manufactured today.

Tacit Knowledge 9

Tacit Knowledge Biotechnology Contract Manufacturing Cost 9

Harvard Business Review

AUGUST 4, 2016

In one study, female and male MBA students were paired and asked to negotiate the purported purchase of a biotechnology plant. Everyone in today’s supercharged workplaces experiences stress. Yet executive and professional women consistently experience more stress, anxiety, and psychological distress than do men.

Biotechnology 10

Biotechnology Stress Review Document 10

Harvard Business Review

JUNE 21, 2013

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. But our global survey of more than 1,000 corporate directors, conducted in partnership with WomenCorporateDirectors and Heidrick & Struggles, said otherwise.

Telecommunications 11

Telecommunications Biotechnology Apparel Wireless 11

Harvard Business Review

OCTOBER 1, 2014

More new businesses are better for society, right? That’s a common assumption. For instance, take this recent Washington Post piece , headlined, “More businesses are closing than starting. Can Congress help turn that around?” Sounds ominous at first. But wait a minute – is starting more new businesses always a good thing?

Biotechnology 10

Biotechnology Entrepreneur Real Estate Health Care 10

Harvard Business Review

MARCH 5, 2012

This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. Following up on his pledge to provide greater support for manufacturing in his State of the Union address, President Obama has announced a proposal to cut the effective tax rate for manufacturers to 25%.

Biotechnology 13

Biotechnology Health Care Outsourcing Industry 13

Harvard Business Review

MARCH 1, 2011

And biotechnology and medical devices are among the leading areas for venture capital funding. Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. At first blush, it would appear that entrepreneurship is alive and well in health care.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. Editor's Note: This post was written with Justin Chakma, an undergraduate student at the University of Toronto (Canada).

Biotechnology 15

Biotechnology Venture Capitalist IPO Pharmaceuticals 15

Harvard Business Review

MARCH 1, 2012

For example, in biotechnology, a field in which the U.S. The U.S. competitiveness debate too often devolves into a cry for more Apples and more Ciscos on American shores, when what the country really needs is more Hospiras. More what? Hospira is an advanced contract manufacturer. A freelancer, if you will. It's a private, independent company in the Chicago area that handles biopharma production for a number of partners.

Offshoring 13

Offshoring Contract Manufacturing Biotechnology Supply Chain 13